Evidence map›Paper›PMID 37686224›Full record

ArticleInternational journal of molecular sciences2023

An Increase in Mucin2 Expression Is Required for Colon Cancer Progression Mediated by L1.

Arka Saha, Nancy Gavert, Thomas Brabletz, Avri Ben-Ze'ev

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Arka SahaDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Nancy GavertDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.ORCID 0000-0003-1639-4684
Thomas BrabletzDepartment of Experimental Medicine I, Nikolaus-Feibiger-Center for Molecular Medicine, University of Erlangen-Nuernberg, 91054 Erlangen, Germany.
Avri Ben-Ze'evDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.ORCID 0000-0001-6113-3921
Weizmann Institute of Science · ILFriedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

Deutsche Forschungsgemeinschaft TRR305 and BR1399/9-1, BR1399/10-1Weizmann Institute of Science Dean of the Faculty of Biology
6 · The paper itself

Abstract

An induction in the expression of the cell adhesion receptor L1, a Wnt target gene, is a characteristic feature of Wnt/β-catenin activation in colon cancer cells at later stages of the disease. We investigated the proteins secreted following L1 expression in colon cancer cells and identified Mucin2 among the most abundant secreted proteins. We found that suppressing Mucin2 expression in L1-expressing colon cancer cells inhibits cell proliferation, motility, tumorigenesis, and liver metastasis. We detected several signaling pathways involved in Mucin2 induction in L1-expressing cells. In human colon cancer tissue, Mucin2 expression was significantly reduced or lost in the adenocarcinoma tissue, while in the mucinous subtype of colon cancer tissue, Mucin2 expression was increased. An increased signature of

Indexed as

Colonic NeoplasmsLiver NeoplasmsCarcinogenesisCell Transformation, NeoplasticHumansMucin-2Neural Cell Adhesion Molecule L1L1CAM protein, humanMUC2 protein, humanMucin-2Neural Cell Adhesion Molecule L1colon cancerL1metastasisMucin2tumorigenesis

Identifiers

PMID37686224
PMCPMC10488000
OpenAlexW4386285458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.